| 000 | 02325 a2200349 4500 | ||
|---|---|---|---|
| 001 | 1138077453 | ||
| 005 | 20250317100411.0 | ||
| 008 | 250312042017xx 59 eng | ||
| 020 | _a9781138077454 | ||
| 037 |
_bTaylor & Francis _cGBP 97.99 _fBB |
||
| 040 | _a01 | ||
| 041 | _aeng | ||
| 072 | 7 |
_aMJD _2thema |
|
| 072 | 7 |
_aP _2thema |
|
| 072 | 7 |
_aTGM _2thema |
|
| 072 | 7 |
_aTDCP _2thema |
|
| 072 | 7 |
_aMJD _2bic |
|
| 072 | 7 |
_aP _2bic |
|
| 072 | 7 |
_aTGM _2bic |
|
| 072 | 7 |
_aTDCP _2bic |
|
| 072 | 7 |
_aMED010000 _2bisac |
|
| 072 | 7 |
_aTEC021000 _2bisac |
|
| 072 | 7 |
_a547.7 _2bisac |
|
| 100 | 1 | _aShalaby W. Shalaby | |
| 245 | 1 | 0 | _aPolymers for Vascular and Urogenital Applications |
| 250 | _a1 | ||
| 260 |
_bCRC Press _c20170406 |
||
| 300 | _a274 p | ||
| 520 | _bIn a carefully crafted, multidisciplinary, skillfully focused format, Polymers for Vascular and Urogenital Applications covers attributes of polymers used for vascular, urological, and gynecological materials. It provides a brief analysis of how the use of polymers in vascular and urogenital applications has evolved in the past five decades and outlines their common and specific functional requirements. The book provides a brief description of the evolving role of a particular family of materials and presents topics in highly integrated, well-balanced, authoritatively prepared segments on materials processing and in vitro and in vivo evaluation, complete with case studies. Features Includes contributions from authors representing a diverse technical group of clinicians with strong science or engineering backgrounds and research interests Supplies a comprehensive link between polymeric biomaterials and their application Provides a brief description of the evolving role of a particular family of materials Discusses recent developments in applications and the rationale for present and future clinical significance This book not only integrates clinical needs with current and future research responses but also provides a comprehensive overview to foster future innovation. It illustrates how two important and dissimilar areas in medicine can be interrelated by shared biomaterials and explores the clinical paradigm that establishes the driving force for innovation. | ||
| 700 | 1 |
_aKaren J.L. Burg _4B01 |
|
| 700 | 1 |
_aWaleed Shalaby _4B01 |
|
| 999 |
_c2359 _d2359 |
||